Amryt Pharma PLC Holding(s) in Company (9464Z)
15 Gennaio 2020 - 06:16PM
UK Regulatory
TIDMAMYT
RNS Number : 9464Z
Amryt Pharma PLC
15 January 2020
TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and
to the FCA in Microsoft Word format if possible)(i)
1a. Identity of the issuer or the underlying Amryt Pharma plc
issuer of existing shares to which voting
rights are attached(ii) :
------------------------------------
1b. Please indicate if the issuer is a non-UK issuer (please mark with
an "X" if appropriate)
Non-UK issuer
----
2. Reason for the notification (please mark the appropriate box or boxes
with an "X")
An acquisition or disposal of voting rights X
----
An acquisition or disposal of financial instruments
----
An event changing the breakdown of voting rights
----
Other (please specify)(iii) :
----
3. Details of person subject to the notification obligation(iv)
Name Highbridge Capital Management
LLC
City and country of registered office (if New York, United States
applicable)
4. Full name of shareholder(s) (if different from 3.)(v)
Name
------------------------------------
City and country of registered office (if
applicable)
------------------------------------
5. Date on which the threshold was crossed 10 January 2020
or reached(vi) :
------------------------------------
6. Date on which issuer notified (DD/MM/YYYY): 13 January 2020
------------------------------------
7. Total positions of person(s) subject to the notification obligation
% of voting % of voting rights Total of both Total number
rights attached through financial in % (8.A + of voting rights
to shares (total instruments 8.B) of issuer(vii)
of 8. A) (total of 8.B
1 + 8.B 2)
------------------ ------------------- -------------- --------------------
Resulting situation
on the date
on which threshold
was crossed
or reached 4.92% 2.07% 6.99% 154,498,887
------------------ ------------------- -------------- --------------------
Position of
previous notification
(if
applicable) 5.09% 2.07% 7.16%
------------------ ------------------- -------------- --------------------
8. Notified details of the resulting situation on the date on which the
threshold was crossed or reached(viii)
A: Voting rights attached to shares
Class/type of Number of voting rights(ix) % of voting rights
shares
ISIN code (if
possible)
Direct Indirect Direct Indirect
(Art 9 of Directive (Art 10 of Directive (Art 9 of Directive (Art 10 of Directive
2004/109/EC) 2004/109/EC) 2004/109/EC) 2004/109/EC)
(DTR5.1) (DTR5.2.1) (DTR5.1) (DTR5.2.1)
------------------------
GB00BKLTQ412 7,594,695 4.92%
-------------------------- ------------------------ -------------------- ---------------------
SUBTOTAL 8. A 7,594,695 4.92%
---------------------------------------------------- -------------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC
(DTR5.3.1.1 (a))
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date(x) Conversion Period(xi) rights that may rights
be acquired if
the instrument
is
exercised/converted.
---------------- ----------------------------- ------------------------- ---------------------
American
Depository
Receipt n/a n/a 3,204,130 2.07%
---------------- ----------------------------- ------------------------- ---------------------
SUBTOTAL 8. B
1 3,204,130 2.07%
----------------------------- ------------------------- ---------------------
B 2: Financial Instruments with similar economic effect according to
Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of financial Expiration Exercise/ Physical or Number of % of voting
instrument date(x) Conversion cash voting rights rights
Period (xi) settlement(xii)
----------- ------------- ----------------- ---------------
SUBTOTAL 8.B.2
----------------- ---------------
9. Information in relation to the person subject to the notification
obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is not controlled
by any natural person or legal entity and does not control any other
undertaking(s) holding directly or indirectly an interest in the
(underlying) issuer(xiii)
Full chain of controlled undertakings through which the voting rights X
and/or the
financial instruments are effectively held starting with the ultimate
controlling natural person or legal entity(xiv) (please add additional
rows as necessary)
Name(xv) % of voting rights % of voting rights Total of both if
if it equals or through financial it equals or is
is higher than the instruments if it higher than the
notifiable threshold equals or is higher notifiable threshold
than the notifiable
threshold
----------------------- ---------------------- ------------------------
JPMorgan Asset Management
Holdings Inc.
----------------------- ---------------------- ------------------------
Highbridge Capital
Management, LLC 6.99%
------------------------
10. In case of proxy voting, please identify:
Name of the proxy holder N/A
------------------------------------------------
The number and % of voting rights N/A
held
------------------------------------------------
The date until which the voting rights N/A
will be held
------------------------------------------------
11. Additional information(xvi)
Chain of controlled undertakings:
JPMorgan Asset Management Holdings Inc.
Highbridge Capital Management, LLC
Place of completion London, United Kingdom
Date of completion 13 January 2020
-----------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
HOLMZGMMNKDGGZM
(END) Dow Jones Newswires
January 15, 2020 12:16 ET (17:16 GMT)
Grafico Azioni Amryt Pharma (LSE:AMYT)
Storico
Da Feb 2024 a Mar 2024
Grafico Azioni Amryt Pharma (LSE:AMYT)
Storico
Da Mar 2023 a Mar 2024
Notizie in Tempo Reale relative a Amryt Pharma Plc (Borsa di Londra): 0 articoli recenti
Più Amryt Pharma Plc Articoli Notizie